CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities
Net income	$ 5,249,663	$ 3,422,098
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	9,647,751	9,167,516
Amortization of deferred finance costs	141,404	141,122
(Income) from investments in joint venture	(2,721,231)	(1,220,666)
Gain on sale of real estate		(103,793)
Change in operating assets and liabilities
Decrease in rents receivable	8,579	(202,024)
(Decrease) in accounts payable and accrued expense	(552,022)	(1,760,588)
Decrease in insurance recovery receivable	311,218	190,781
Decrease (Increase) in real estate tax escrow	(37,357)	(47,365)
Decrease in prepaid expenses and other assets	(221,852)	498,350
Increase in advance rental payments and security deposits	201,385	77,127
Total Adjustments	6,777,875	6,740,460
Net cash provided by operating activities	12,027,538	10,162,558
Cash Flows From Investing Activities
Proceeds from unconsolidated joint ventures	4,901,250	2,346,829
Distribution in excess of investment in unconsolidated joint ventures	468,420	360,000
(Investment) in unconsolidated joint ventures	(2,604,170)	(2,443,829)
Improvement of rental properties	(4,135,472)	(3,564,402)
Purchase of rental property	(45,571,670)
Net proceeds from the sale of real estate		772,336
Net cash (used in) investing activities	(46,941,642)	(2,529,066)
Cash Flows from Financing Activities
Payment of financing costs	(176,250)	(174,718)
Proceeds of mortgage notes payable	22,250,000	20,071,000
Proceeds of note payable	41,000,000
Payment of note payable	(16,000,000)	(25,000,000)
Principal payments of mortgage notes payable	(1,308,735)	(1,449,221)
Stock buyback	(42,548)	(694,380)
Distributions to partners	(3,358,648)	(2,810,776)
Net cash (used in) financing activities	42,363,819	(10,058,095)
Net (Decrease) in Cash and Cash Equivalents	7,449,715	(2,424,603)
Cash and Cash Equivalents, at beginning of period	7,463,697	10,298,186
Cash and Cash Equivalents, at end of period	$ 14,913,412	$ 7,873,583